trending Market Intelligence /marketintelligence/en/news-insights/trending/hmvxsvudrtumpuekd73yug2 content esgSubNav
In This List

Chembio Diagnostics appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Chembio Diagnostics appoints director

Chembio Diagnostics Inc. appointed John Potthoff to its board.

Potthoff is the CEO of Elligo Health Research Inc., a clinical research company in Austin, Texas.

Medford, N.Y.-based Chembio Diagnostics develops point-of-care diagnostic tests that are used to detect or monitor diseases.